Abstract
Three decades after the beginning of the study of the Wnt signaling pathway, major contributions have been made to elucidate the molecular mechanisms that regulate this signaling pathway and its role in development, homeostasis and disease. However, there is still a lack of understanding about the relationships between Wnt signaling and cell-extracellular matrix (ECM) adhesion. Data gathered in the last years is helping to uncover these relationships. Several ECM proteins are able to regulate components of the Wnt pathway during development and disease, and their misregulation leads to changes in Wnt signaling. Fibronectin, a major ECM protein, regulates non-canonical Wnt signaling during embryogenesis in Xenopus and in muscle regeneration in mouse, whereas it modulates canonical Wnt signaling through modulation of β -catenin. Integrins, which act as Fibronectin receptors, also modulate Wnt activity, and Syndecan-4, a heparan sulphate proteoglycan, is able to regulate canonical and non-canonical Wnt pathways, notably during embryogenesis. Other secreted ECM proteins have been recently associated to the regulation of Wnt signaling, albeit molecular mechanisms are still unclear. The non-canonical Wnt pathway plays a role in the regulation of the ECM assembly, and modulates focal adhesion dynamics through the involvement of Wnt components, whereas Wnt/β-catenin signaling regulates the expression of genes encoding ECM proteins. This evidence indicates that Wnt signaling and cell-ECM adhesion are two closely related processes, and alterations in this cross-talk might be involved in disease.
Keywords: Adhesion, extracellular matrix, Fibronectin, focal adhesion, Integrin, stiffness, Syndecan-4, Wnt.
Current Molecular Medicine
Title:Wnt Signaling and Cell-Matrix Adhesion
Volume: 14 Issue: 2
Author(s): P. Astudillo and J. Larrain
Affiliation:
Keywords: Adhesion, extracellular matrix, Fibronectin, focal adhesion, Integrin, stiffness, Syndecan-4, Wnt.
Abstract: Three decades after the beginning of the study of the Wnt signaling pathway, major contributions have been made to elucidate the molecular mechanisms that regulate this signaling pathway and its role in development, homeostasis and disease. However, there is still a lack of understanding about the relationships between Wnt signaling and cell-extracellular matrix (ECM) adhesion. Data gathered in the last years is helping to uncover these relationships. Several ECM proteins are able to regulate components of the Wnt pathway during development and disease, and their misregulation leads to changes in Wnt signaling. Fibronectin, a major ECM protein, regulates non-canonical Wnt signaling during embryogenesis in Xenopus and in muscle regeneration in mouse, whereas it modulates canonical Wnt signaling through modulation of β -catenin. Integrins, which act as Fibronectin receptors, also modulate Wnt activity, and Syndecan-4, a heparan sulphate proteoglycan, is able to regulate canonical and non-canonical Wnt pathways, notably during embryogenesis. Other secreted ECM proteins have been recently associated to the regulation of Wnt signaling, albeit molecular mechanisms are still unclear. The non-canonical Wnt pathway plays a role in the regulation of the ECM assembly, and modulates focal adhesion dynamics through the involvement of Wnt components, whereas Wnt/β-catenin signaling regulates the expression of genes encoding ECM proteins. This evidence indicates that Wnt signaling and cell-ECM adhesion are two closely related processes, and alterations in this cross-talk might be involved in disease.
Export Options
About this article
Cite this article as:
Astudillo P. and Larrain J., Wnt Signaling and Cell-Matrix Adhesion, Current Molecular Medicine 2014; 14 (2) . https://dx.doi.org/10.2174/1566524014666140128105352
| DOI https://dx.doi.org/10.2174/1566524014666140128105352 |
Print ISSN 1566-5240 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
Call for Papers in Thematic Issues
From Molecular Mechanisms to Therapeutic Frontiers: The Versatile Roles of Chaperones in Medicine
Chaperones play critical roles in maintaining proteostasis by preventing protein misfolding and aggregation, which constitute central processes to the pathogenesis of numerous diseases such as neurodegeneration, cancer, and inflammatory disorders. This thematic issue will delve into the molecular mechanisms of chaperone function, their involvement in disease progression, and their potential ...read more
Metabolic Reprogramming and Molecular Pharmacology: Innovations in Drug Discovery and Therapeutic Targeting
Metabolic reprogramming is a hallmark of numerous diseases, including cancer, metabolic disorders, and neurodegeneration. Understanding the intricate cell signaling pathways, transduction pathways, and omics-based data is important for the development of novel pharmacological interventions. This special issue of Current Molecular Medicine will be devoted to the current advances in drug ...read more
Molecular and Cellular Mechanisms in Vertigo / Vestibular Disorders
Vertigo and vestibular diseases are common among middle-aged and older adults, significantly increasing the risk of falls and leading to injuries and disabilities. Despite their prevalence, therapeutic advancements are hindered by a limited understanding of the underlying molecular and cellular mechanisms. This Special Issue is dedicated to bridging this gap ...read more
Related Journals
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Dysregulation of Lysyl Oxidases Expression in Diabetic Nephropathy and Renal Cell Carcinoma
Current Drug Targets Modulation of the Immune Response by Targeting Endothelial Cells
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Insight View on Possible Role of Fluoroquinolones in Cancer Therapy
Current Topics in Medicinal Chemistry Nonsteroidal Aromatase Inhibitors for the Treatment of Breast Cancer: An Update
Anti-Cancer Agents in Medicinal Chemistry Epigenetic Regulation of EMT: The Snail Story
Current Pharmaceutical Design The Dual Functions of Non-Coding RNA CRNDE in Different Tumors
Mini-Reviews in Medicinal Chemistry Recent Advances in Selective Estrogen Receptor Modulators for Breast Cancer
Mini-Reviews in Medicinal Chemistry MiR-22-3p Regulates Amyloid β Deposit in Mice Model of Alzheimer's Disease by Targeting Mitogen-activated Protein Kinase 14
Current Neurovascular Research MicroRNA-34a: Role in Cancer and Cardiovascular Disease
Current Drug Targets Targeted Protein Degradation: An Emerging Therapeutic Strategy in Cancer
Anti-Cancer Agents in Medicinal Chemistry Survival Benefit of Adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the Different Time-points of Treatment of Ovarian Cancer: Review of Evidence
Current Pharmaceutical Design Crocetin and Crocin from Saffron in Cancer Chemotherapy and Chemoprevention
Anti-Cancer Agents in Medicinal Chemistry Current Targets for Anticancer Drug Discovery
Current Drug Targets RING Finger E3 Ubiquitin Ligases: Structure and Drug Discovery
Current Pharmaceutical Design VEGF/VEGFR2 Autocrine Signaling Stimulates Metastasis in Prostate Cancer Cells
Current Angiogenesis (Discontinued) A Link Between Chemical Structure and Biological Activity in Triterpenoids
Recent Patents on Anti-Cancer Drug Discovery Meet Our Editorial Board Member
Reviews on Recent Clinical Trials Dasatinib: An Anti-Tumour Agent via Src Inhibition
Current Drug Targets The HOX Genes Network in Uro-Genital Cancers: Mechanisms and Potential Therapeutic Implications
Current Medicinal Chemistry Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation
Current Cancer Drug Targets





